Cargando…
Synthetic lethality of cytolytic HSV-1 in cancer cells with ATRX and PML deficiency
Cancers that utilize the alternative lengthening of telomeres (ALT) mechanism for telomere maintenance are often difficult to treat and have a poor prognosis. They are also commonly deficient for expression of ATRX protein, a repressor of ALT activity, and a component of promyelocytic leukemia nucle...
Autores principales: | Han, Mingqi, Napier, Christine E., Frölich, Sonja, Teber, Erdahl, Wong, Ted, Noble, Jane R., Choi, Eugene H. Y., Everett, Roger D., Cesare, Anthony J., Reddel, Roger R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Company of Biologists Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6432714/ https://www.ncbi.nlm.nih.gov/pubmed/30745338 http://dx.doi.org/10.1242/jcs.222349 |
Ejemplares similares
-
ATRX represses alternative lengthening of telomeres
por: Napier, Christine E., et al.
Publicado: (2015) -
Alternative lengthening of telomeres is not synonymous with mutations in ATRX/DAXX
por: de Nonneville, Alexandre, et al.
Publicado: (2021) -
PML isoforms in response to arsenic: high-resolution analysis of PML body structure and degradation
por: Hands, Katherine J., et al.
Publicado: (2014) -
Loss of Wild-Type ATRX Expression in Somatic Cell Hybrids Segregates with Activation of Alternative Lengthening of Telomeres
por: Bower, Kylie, et al.
Publicado: (2012) -
PML protein organizes heterochromatin domains where it regulates histone H3.3 deposition by ATRX/DAXX
por: Delbarre, Erwan, et al.
Publicado: (2017)